Factors influencing response to intravenous lacosamide in emergency situations: LACO-IV study

Epilepsy and Behavior

Volumn 36, Issue , 2014, Pages 144-152

  Garcés, Mercedes ^a   Villanueva, Vicente ^a   Mauri, José Angel ^b   Suller, Ana ^b   García, Carolina ^b   López González, Franscisco Javier ^c   Rodríguez Osorio, Xiana ^c   Fernández Pajarín, Gustavo ^c   Piera, Anna ^d   Guillamón, Edelmira ^d   Santafé, Consuelo ^d   Castillo, Ascensión ^e   Giner, Pau ^f   Torres, Nerea ^f   Escalza, Inés ^g   del Villar, Ana ^h   García de Casasola, Maria Carmen ⁱ   Bonet, Macarena ^j   Noé, Enrique ^k   Olmedilla, Nuria ^l  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^c Fac Med de Santiago de Compostela   (Spain)

^d HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^e Hospital General Universitario Valencia   (Spain)

^f HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^g HOSPITAL DE GALDAKAO   (Spain)

^h HOSPITAL GENERAL DE CASTELLÓN   (Spain)

ⁱ Hospital Santa Cruz de Liencres   (Spain)

^j HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

^k Hospital NISAValencia Al Mar   (Spain)

^l HOSPITAL CENTRAL DE LA DEFENSA GÓMEZ ULLA   (Spain)

more..

Author keywords

Acute repetitive seizures; Emergency setting; Intravenous (IV) lacosamide; Retrospective study; Status epilepticus

Indexed keywords

BENZODIAZEPINE; ETIRACETAM; HARKOSERIDE; PHENYTOIN; SODIUM CHANNEL BLOCKING AGENT; VALPROIC ACID; ACETAMIDE DERIVATIVE; ANTICONVULSIVE AGENT;

ADD ON THERAPY; ADULT; AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPLOPIA; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; DRUG TOLERABILITY; DRUG USE; DRUG WITHDRAWAL; EMERGENCY; EPILEPTIC STATE; FEMALE; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTICENTER STUDY; OBSERVATIONAL STUDY; PR INTERVAL PROLONGATION; STANDARD; TREATMENT RESPONSE; VERY ELDERLY; VOMITING; ADOLESCENT; CLINICAL TRIAL; DRUG EFFECTS; EMERGENCY HEALTH SERVICE; FACTORIAL ANALYSIS; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; OBSERVATION; REACTION TIME; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; STATUS EPILEPTICUS; TIME; TREATMENT OUTCOME; YOUNG ADULT;

ACETAMIDES; ADMINISTRATION, INTRAVENOUS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; COHORT STUDIES; EMERGENCY SERVICE, HOSPITAL; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; OBSERVATION; REACTION TIME; STATUS EPILEPTICUS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84902161471     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2014.05.015     Document Type: Article

References (54)

1. Lowenstein D.H., Alldredge B.K. Status epilepticus. N Engl J Med 1998, 338(14):970-976.
2. Coeytaux A., Jallon P., Galobardes B., Morabia A. Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR). Neurology 2000, 55(5):693-697.
3. DeLorenzo R.J., Hauser W.A., Towne A.R., Boggs J.G., Pellock J.M., Penberthy L., et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996, 46(4):1029-1035.
4. Novy J., Logroscino G., Rossetti A.O. Refractory status epilepticus: a prospective observational study. Epilepsia 2010, 51(2):251-256.
5. Aranda A., Foucart G., Ducasse J.L., Grolleau S., McGonigal A., Valton L. Generalized convulsive status epilepticus management in adults: a cohort study with evaluation of professional practice. Epilepsia 2010, 51(10):2159-2167.
6. Holtkamp M., Othman J., Buchheim K., Meierkord H. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry 2005, 76(4):534-539.
7. Mitchell W.G. Status epilepticus and acute repetitive seizures in children, adolescents, and young adults: etiology, outcome, and treatment. Epilepsia 1996, 37(Suppl. 1):S74-S80.
8. Meierkord H., Boon P., Engelsen B., Gocke K., Shorvon S., Tinuper P., et al. EFNS guideline on the management of status epilepticus in adults. Eur J Neurol 2010, 17(3):348-355.
9. Brophy G.M., Bell R., Claassen J., Alldredge B., Bleck T.P., Glauser T., et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 2012, 17(1):3-23.
10. Treiman D.M., Meyers P.D., Walton N.Y., Collins J.F., Colling C., Rowan A.J., et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998, 339(12):792-798.
11. Shorvon S. Clinical trials in acute repetitive seizures and status epilepticus. Epileptic Disord 2012, 14(2):138-147.
12. Misra U.K., Kalita J., Patel R. Sodium valproate vs phenytoin in status epilepticus: a pilot study. Neurology 2006, 67(2):340-342.
13. Aiguabella M., Falip M., Villanueva V., de la Pena P., Molins A., Garcia-Morales I., et al. Efficacy of intravenous levetiracetam as an add-on treatment in status epilepticus: a multicentric observational study. Seizure 2011, 20(1):60-64.
14. Hottinger A., Sutter R., Marsch S., Ruegg S. Topiramate as an adjunctive treatment in patients with refractory status epilepticus: an observational cohort study. CNS Drugs 2012, 26(9):761-772.
15. UCB Pharma SA Vimpat 10mg/mL solution for infusion: summary of product characteristics [Accessed Nov 5 2013]. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000863/WC500050338.pdf.
16. Ben-Menachem E., Biton V., Jatuzis D., Abou-Khalil B., Doty P., Rudd G.D. Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures. Epilepsia 2007, 48(7):1308-1317.
17. Chung S., Sperling M.R., Biton V., Krauss G., Hebert D., Rudd G.D., et al. Lacosamide as adjunctive therapy for partial-onset seizures: a randomized controlled trial. Epilepsia 2010, 51(6):958-967.
18. Halasz P., Kalviainen R., Mazurkiewicz-Beldzinska M., Rosenow F., Doty P., Hebert D., et al. Adjunctive lacosamide for partial-onset seizures: efficacy and safety results from a randomized controlled trial. Epilepsia 2009, 50(3):443-453.
19. Biton V., Rosenfeld W.E., Whitesides J., Fountain N.B., Vaiciene N., Rudd G.D. Intravenous lacosamide as replacement for oral lacosamide in patients with partial-onset seizures. Epilepsia 2008, 49(3):418-424.
20. Krauss G., Ben-Menachem E., Mameniskiene R., Vaiciene-Magistris N., Brock M., Whitesides J.G., et al. Intravenous lacosamide as short-term replacement for oral lacosamide in partial-onset seizures. Epilepsia 2010, 51(6):951-957.
21. Goodwin H., Hinson H.E., Shermock K.M., Karanjia N., Lewin J.J. The use of lacosamide in refractory status epilepticus. Neurocrit Care 2011, 14(3):348-353.
22. Hofler J., Unterberger I., Dobesberger J., Kuchukhidze G., Walser G., Trinka E. Intravenous lacosamide in status epilepticus and seizure clusters. Epilepsia 2011, 52(10):e148-e152.
23. Kellinghaus C., Berning S., Immisch I., Larch J., Rosenow F., Rossetti A.O., et al. Intravenous lacosamide for treatment of status epilepticus. Acta Neurol Scand 2011, 123(2):137-141.
24. Koubeissi M.Z., Mayor C.L., Estephan B., Rashid S., Azar N.J. Efficacy and safety of intravenous lacosamide in refractory nonconvulsive status epilepticus. Acta Neurol Scand 2011, 123(2):142-146.
25. Legros B., Depondt C., Levy-Nogueira M., Ligot N., Mavroudakis N., Naeije G., et al. Intravenous lacosamide in refractory seizure clusters and status epilepticus: comparison of 200 and 400mg loading doses. Neurocrit Care 2013, [Epub ahead of print].
26. Miro J., Toledo M., Santamarina E., Ricciardi A.C., Villanueva V., Pato A., et al. Efficacy of intravenous lacosamide as an add-on treatment in refractory status epilepticus: a multicentric prospective study. Seizure 2013, 22(1):77-79.
27. Mnatsakanyan L., Chung J.M., Tsimerinov E.I., Eliashiv D.S. Intravenous lacosamide in refractory nonconvulsive status epilepticus. Seizure 2012, 21(3):198-201.
28. Rantsch K., Walter U., Wittstock M., Benecke R., Rosche J. Efficacy of intravenous lacosamide in refractory nonconvulsive status epilepticus and simple partial status epilepticus. Seizure 2011, 20(7):529-532.
29. Santamarina E., Toledo M., Sueiras M., Raspall M., Ailouti N., Lainez E., et al. Usefulness of intravenous lacosamide in status epilepticus. J Neurol 2013, 260(12):3122-3128.
30. Cherry S., Judd L., Muniz J.C., Elzawahry H., LaRoche S. Safety and efficacy of lacosamide in the intensive care unit. Neurocrit Care 2012, 16(2):294-298.
31. Kellinghaus C., Berning S., Stogbauer F. Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus. Acta Neurol Scand 2013, 10.1111/ane.12174.
32. Hofler J., Trinka E. Lacosamide as a new treatment option in status epilepticus. Epilepsia 2013, 54(3):393-404.
33. Commission on Classification and Terminology of the International League Against Epilepsy Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981, 22(4):489-501.
34. Lowenstein D.H. Status epilepticus: an overview of the clinical problem. Epilepsia 1999, 40(Suppl. 1):S3-S8. [discussion S21-2].
35. Holtkamp M., Meierkord H. Nonconvulsive status epilepticus: a diagnostic and therapeutic challenge in the intensive care setting. Ther Adv Neurol Disord 2011, 4(3):169-181.
36. Beniczky S., Hirsch L.J., Kaplan P.W., Pressler R., Bauer G., Aurlien H., et al. Unified EEG terminology and criteria for nonconvulsive status epilepticus. Epilepsia 2013, 54(Suppl. 6):28-29.
37. Beghi E., Carpio A., Forsgren L., Hesdorffer D.C., Malmgren K., Sander J.W., et al. Recommendation for a definition of acute symptomatic seizure. Epilepsia 2010, 51(4):671-675.
38. Shorvon S., Baulac M., Cross H., Trinka E., Walker M. The drug treatment of status epilepticus in Europe: consensus document from a workshop at the first London Colloquium on Status Epilepticus. Epilepsia 2008, 49(7):1277-1285.
39. Albers J.M., Moddel G., Dittrich R., Steidl C., Suntrup S., Ringelstein E.B., et al. Intravenous lacosamide - an effective add-on treatment of refractory status epilepticus. Seizure 2011, 20(5):428-430.
40. Jain V., Harvey A.S. Treatment of refractory tonic status epilepticus with intravenous lacosamide. Epilepsia 2012, 53(4):761-762.
41. Parkerson K.A., Reinsberger C., Chou S.H., Dworetzky B.A., Lee J.W. Lacosamide in the treatment of acute recurrent seizures and periodic epileptiform patterns in critically ill patients. Epilepsy Behav 2011, 20(1):48-51.
42. Riss J., Cloyd J., Gates J., Collins S. Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand 2008, 118(2):69-86.
43. Wasterlain C.G., Baldwin R., Naylor D.E., Thompson K.W., Suchomelova L., Niquet J. Rational polytherapy in the treatment of acute seizures and status epilepticus. Epilepsia 2011, 52(Suppl. 8):70-71.
44. Sutula T.P., Hagen J., Pitkanen A. Do epileptic seizures damage the brain?. Curr Opin Neurol 2003, 16(2):189-195.
45. Hillman J., Lehtimaki K., Peltola J., Liimatainen S. Clinical significance of treatment delay in status epilepticus. Int J Emerg Med 2013, 6(1):6.
46. Young G.B., Jordan K.G., Doig G.S. An assessment of nonconvulsive seizures in the intensive care unit using continuous EEG monitoring: an investigation of variables associated with mortality. Neurology 1996, 47(1):83-89.
47. Villanueva V., Lopez F.J., Serratosa J.M., Gonzalez-Giraldez B., Campos D., Molins A., et al. Control of seizures in different stages of partial epilepsy: LACO-EXP, a Spanish retrospective study of lacosamide. Epilepsy Behav 2013, 29(2):349-356.
48. Shaibani A., Fares S., Selam J.L., Arslanian A., Simpson J., Sen D., et al. Lacosamide in painful diabetic neuropathy: an 18-week double-blind placebo-controlled trial. J Pain 2009, 10(8):818-828.
49. Wymer J.P., Simpson J., Sen D., Bongardt S. Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens. Clin J Pain 2009, 25(5):376-385.
50. Degiorgio C.M. Atrial flutter/atrial fibrillation associated with lacosamide for partial seizures. Epilepsy Behav 2010, 18(3):322-324.
51. Nizam A., Mylavarapu K., Thomas D., Briskin K., Wu B., Saluja D., et al. Lacosamide-induced second-degree atrioventricular block in a patient with partial epilepsy. Epilepsia 2011, 52(10):e153-e155.
52. Krause L.U., Brodowski K.O., Kellinghaus C. Atrioventricular block following lacosamide intoxication. Epilepsy Behav 2011, 20(4):725-727.
53. Aksakal E., Bakirci E.M., Emet M., Uzkeser M. Complete atrioventricular block due to overdose of pregabalin. Am J Emerg Med 2012, 30(9):2101. [e1-4].
54. Hocker S., Prasad A., Rabinstein A.A. Cardiac injury in refractory status epilepticus. Epilepsia 2013, 54(3):518-522.